**Core Concept**
Accelerated partial breast irradiation (APBI) is a radiation therapy technique used to treat early-stage breast cancer. It delivers a concentrated dose of radiation to the tumor bed, sparing the surrounding healthy tissue.

**Why the Correct Answer is Right**
APBI is typically reserved for patients with low-risk breast cancer, such as those with small tumors (≤ 2 cm) and negative lymph nodes. The technique involves delivering a higher dose of radiation over a shorter period, usually 5-10 days, compared to traditional whole-breast radiation therapy. This accelerated schedule helps to minimize the duration of radiation exposure and reduces the risk of radiation-induced side effects.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is not provided, but typically, APBI is not typically used for patients with multicentric tumors. This is because APBI is designed to target a single tumor site, and multicentric tumors require a more extensive radiation field.

**Option B:** APBI is not typically used for patients with ductal carcinoma in situ (DCIS) with high-grade features. This is because APBI's efficacy in treating high-grade DCIS is unclear, and whole-breast radiation therapy may be a better option.

**Option C:** APBI is not typically used for patients with a history of chest wall radiation. This is because radiation-induced fibrosis and skin changes can increase the risk of complications during APBI.

**Option D:** APBI is not typically used for patients with a history of connective tissue disease. This is because radiation-induced fibrosis and skin changes can worsen symptoms in patients with pre-existing connective tissue disease.

**Clinical Pearl / High-Yield Fact**
When considering APBI, it's essential to carefully select patients based on tumor characteristics, patient factors, and radiation tolerance. A thorough evaluation of the tumor bed and surrounding tissues is crucial to minimize the risk of complications.

**Correct Answer: None of the above**